Выходит 4 номеров в год
ISSN Печать: 1050-6934
ISSN Онлайн: 1940-4379
Indexed in
Cost of Antibiotic Beads is Justified: A Study of Open Fracture Wounds and Chronic Osteomyelitis
Краткое описание
BackgroundThe purpose of this study was to track the cost of antibiotic-impregnated bead chains and the outcome of treatment over a 30-month period occurring before USP Chapter 797 went into effect. Our overall objective was to determine whether the costs of antibiotic beads were justified by reduced rates of active infections associated with open fracture wounds or chronic osteomyelitis. MethodsWe retrospectively reviewed 125 patients with open fracture wounds (Group 1) and 16 patients with chronic osteomyelitis (Group 2) treated over a 2.5-year period. We reviewed the medical records and performed cost calculations for the beads. The minimum time from treatment to the latest follow-up evaluation was six weeks (average, 30.7 weeks; range, 6-134 weeks) for Group 1 and six months (average, 61.8 weeks; range, 24−156 weeks) for Group 2. ResultsThe overall infection rates were 3.2% (96.8% free of active infection) for Group 1 and 25.0% (75.0% free of active infection) for Group 2. The average cost of antibiotic bead treatment per patient was $419.36 for Group 1 and $484.54 for Group 2. ConclusionsThe costs of antibiotic beads to prevent active infection of open fracture wounds or to treat active infection associated with chronic osteomyelitis are justified based on the cost structure prior to the impact of new federal regulations (USP Chapter 797 regulations). We anticipate that the cost of antibiotic beads will increase dramatically with these new regulations.
-
Campoccia Davide, Montanaro Lucio, Speziale Pietro, Arciola Carla Renata, Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use, Biomaterials, 31, 25, 2010. Crossref
-
Ambrose Catherine G., Clyburn Terry A., Mika Joerg, Gogola Gloria R., Kaplan Heidi B., Wanger Audrey, Mikos Antonios G., Evaluation of Antibiotic-Impregnated Microspheres for the Prevention of Implant-Associated Orthopaedic Infections, Journal of Bone and Joint Surgery, 96, 2, 2014. Crossref
-
Byren I, Peters EJG, Hoey C, Berendt A, Lipsky BA, Pharmacotherapy of diabetic foot osteomyelitis, Expert Opinion on Pharmacotherapy, 10, 18, 2009. Crossref
-
Kobata Silvia Iovine, Teixeira Luiz Eduardo Moreira, Fernandes Simone Odilia Antunes, Faraco André Augusto Gomes, Vidigal Paula Vieira Teixeira, Araújo Ivana Duval de, Prevention of bone infection after open fracture using a chitosan with ciprofloxacin implant in animal model, Acta Cirúrgica Brasileira, 35, 8, 2020. Crossref
-
Coleman Michelle C., Whitfield-Cargile Canaan, Chesen Berkley, Williams Jarred, Romano Juan E., Hardy Joanne, MacKay Evelyn, Washburn Kevin, Sampson Sarah N., Gibbons Phillippa, Loinaz Ricardo, Reuss Sarah M., Chaffin M. Keith, Jones Meredyth L., Watts Ashlee E., Swor Tamara M., Hartnack Amanda K., Tull Travis M., Norman Tracy E., Watkins Jeffrey P., Jordan Will C., Katzman Scott A., Diseases of the Bones, Joints, and Connective Tissues, in Large Animal Internal Medicine, 2020. Crossref
-
Morgenstern M., Vallejo A., McNally M. A., Moriarty T. F., Ferguson J. Y., Nijs S., Metsemakers WJ., The effect of local antibiotic prophylaxis when treating open limb fractures, Bone & Joint Research, 7, 7, 2018. Crossref